Slavcev R - Search Results

1

Construction and analysis of a genetically tuneable lytic phage display system.

Nicastro J, Sheldon K, El-Zarkout FA, Sokolenko S, Aucoin MG, Slavcev R. Nicastro J, et al. Among authors: slavcev r. Appl Microbiol Biotechnol. 2013 Sep;97(17):7791-804. doi: 10.1007/s00253-013-4898-6. Epub 2013 May 3. Appl Microbiol Biotechnol. 2013. PMID: 23640362 Free PMC article.

2

Graphical analysis of flow cytometer data for characterizing controlled fluorescent protein display on λ phage.

Sokolenko S, Nicastro J, Slavcev R, Aucoin MG. Sokolenko S, et al. Among authors: slavcev r. Cytometry A. 2012 Dec;81(12):1031-9. doi: 10.1002/cyto.a.22211. Epub 2012 Oct 1. Cytometry A. 2012. PMID: 23027705 Free article.

3

Bacteriophage recombination systems and biotechnical applications.

Nafissi N, Slavcev R. Nafissi N, et al. Among authors: slavcev r. Appl Microbiol Biotechnol. 2014 Apr;98(7):2841-51. doi: 10.1007/s00253-014-5512-2. Epub 2014 Jan 19. Appl Microbiol Biotechnol. 2014. PMID: 24442504 Review.

4

Bacteriophage lambda display systems: developments and applications.

Nicastro J, Sheldon K, Slavcev RA. Nicastro J, et al. Appl Microbiol Biotechnol. 2014 Apr;98(7):2853-66. doi: 10.1007/s00253-014-5521-1. Epub 2014 Jan 19. Appl Microbiol Biotechnol. 2014. PMID: 24442507 Review.

5

Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8⁺ T response.

Arab A, Nicastro J, Slavcev R, Razazan A, Barati N, Nikpoor AR, Brojeni AAM, Mosaffa F, Badiee A, Jaafari MR, Behravan J. Arab A, et al. Among authors: slavcev r. Immunol Res. 2018 Feb;66(1):200-206. doi: 10.1007/s12026-017-8969-0. Immunol Res. 2018. PMID: 29143917

6

Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice.

Barati N, Razazan A, Nicastro J, Slavcev R, Arab A, Mosaffa F, Nikpoor AR, Badiee A, Jaafari MR, Behravan J. Barati N, et al. Among authors: slavcev r. Cancer Lett. 2018 Jun 28;424:109-116. doi: 10.1016/j.canlet.2018.03.030. Epub 2018 Mar 23. Cancer Lett. 2018. PMID: 29580807

7

Phage-based Nanomedicines as New Immune Therapeutic Agents for Breast Cancer.

Arab A, Robati RY, Nicastro J, Slavcev R, Behravan J. Arab A, et al. Among authors: slavcev r. Curr Pharm Des. 2018;24(11):1195-1203. doi: 10.2174/1381612824666180327152117. Curr Pharm Des. 2018. PMID: 29589543 Review.

8

The viral approach to breast cancer immunotherapy.

Arab A, Behravan N, Razazn A, Barati N, Mosaffa F, Nicastro J, Slavcev R, Behravan J. Arab A, et al. Among authors: slavcev r. J Cell Physiol. 2019 Feb;234(2):1257-1267. doi: 10.1002/jcp.27150. Epub 2018 Aug 26. J Cell Physiol. 2019. PMID: 30146692 Review.

9

Specific Systems for Imaging.

Sum CH, Shortall SM, Nicastro JA, Slavcev R. Sum CH, et al. Among authors: slavcev r. Exp Suppl. 2018;110:69-97. doi: 10.1007/978-3-319-78259-1_3. Exp Suppl. 2018. PMID: 30536227

10

Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice.

Razazan A, Nicastro J, Slavcev R, Barati N, Arab A, Mosaffa F, Jaafari MR, Behravan J. Razazan A, et al. Among authors: slavcev r. Sci Rep. 2019 Feb 18;9(1):2221. doi: 10.1038/s41598-018-38371-z. Sci Rep. 2019. PMID: 30778090 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page